We inform you that Mr. Nilesh Thakkar has resigned from the Company as the Vice President - Head Business Development(international) w.e.f. November 30, 2024.
Announcement under Regulation 30 (LODR)-Cessation
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Nov 21 2024
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Shareholder Meeting / Postal Ballot-Outcome of EGM
- Sudarshan Pharma Industries Ltd Press Release Nov 18 2024
- Addendum To The Notice Of The Extraordinary General Meeting Of Sudarshan Pharma Industries Limited Held On Monday, 30Th September, 2024
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Acquisition
- Sudarshan Pharma Industries Ltd Press Release Nov 29 2024
- Board Meeting Outcome for Allotment Of 9,00,000 Convertible Warrants On Preferential Basis To The Promoters Of The Company
- Sudarshan Pharma Industries Ltd Press Release Dec 18 2024
- Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, January 10, 2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries